Ｍ－オンコリスバイオ：Announcement of FDA Clearance of Two IND Applications to Initiate Phase 2 Clinical Trials of OBP-601 (Censavudine, TPN-101) - 有報キャッチャー

Ｍ－オンコリスバイオ（4588）　Announcement of FDA Clearance of Two IND Applications to Initiate Phase 2 Clinical Trials of OBP-601 (Censavudine, TPN-101) 2021/08/16

/-

読み込み中…